ANDREW YEE to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications ANDREW YEE has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.720
-
Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma. Blood Adv. 2025 Mar 11; 9(5):1163-1170.
Score: 0.678
-
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma. Leuk Lymphoma. 2024 Dec; 65(12):1789-1800.
Score: 0.041